NDC 72162-2193-01 - Carbidopa and Levodopa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2193
- Requested NDC
- 72162-2193-01
- Package NDCs from labels
- 72162-2193-1, 72162-2193-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-07-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-07-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2193-1 | Carbidopa and Levodopa | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2193 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20231219_3b06a0e2-bec8-4178-942b-67eb47f2916e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2193-1 | EA - Each | 72162-2193 | 1c7774b0-99e6-471f-82fb-4a8d10e3ce2d | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exchange Select Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Army and Air Force Exchange Service | 9e478343-8ae7-823e-e053-2995a90a84ed | 2025-12-30 | Warnings | 3NXW29V3WO |
| DG Health Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYPROPYLENE GLYCOL 400 | Dolgencorp LLC | 9cb20c3b-bf6d-8c7c-e053-2995a90aa485 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Core Values Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Liberty Procurement Co. Inc. | f8285f68-c40c-19a8-e053-6394a90aacad | 2025-12-30 | Warnings | 3NXW29V3WO |
| Harris Teeter Eye Drops Artificial Tears | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Harris Teeter, LLC. | f82957d9-c4ad-a914-e053-6294a90aac50 | 2025-12-30 | Warnings | 3NXW29V3WO |
| CVS Gentle Tears | DEXTRAN 70, HYPROMELLOSE | CVS Pharmacy, Inc. | 9b1ea0eb-c34f-6603-e053-2995a90a6a95 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | 3NXW29V3WO |
| L-Dopa | L-DOPA | BioActive Nutritional, Inc. | bbb3deb1-82f3-4e36-bdc5-9242335e4747 | 2025-12-18 | Warnings | 46627O600J |
| Carbidopa | CARBIDOPA | Edenbridge Pharmaceuticals LLC. | 55b99f22-9eb2-4df6-9979-bc4c3af5e454 | 2025-12-17 | Warnings, Adverse reactions | MNX7R8C5VO |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| High Vitality Tab | AGNUS CASTUS, AMBRA GRISEA, ESTRADIOL, L-DOPA, MELATONIN, PETROSELINUM SATIVUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, SARCOLACTICUM ACIDUM, UBIDECARENONUM, BARYTA CARBONICA, CONIUM MACULATUM, SELENIUM METALLICUM, FOLLICULINUM, TESTOSTERONE, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HYPOTHALAMUS SUIS, LYMPH NODE (SUIS), MEDULLA OSSIS SUIS, OOPHORINUM (SUIS), ORCHITINUM (SUIS), PANCREAS SUIS, SPLEEN (SUIS), PROTEUS (MORGANI) | Deseret Biologicals | d13cfd09-8f8d-4b39-b60e-0e7886af2a56 | 2025-12-11 | Warnings | 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 43ce5061-0830-6f4f-e063-6394a90afc59 | 2025-11-17 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Zydus Pharmaceuticals USA Inc. | 74e7f96b-de31-4e3c-b32d-11421b291d4e | 2025-11-14 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | American Health Packaging | a62ae74d-6677-459c-b338-00e6851a1e00 | 2025-11-13 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Accord Healthcare, Inc. | 5217a6ec-cc26-4acc-b2da-17f6545c3b60 | 2025-10-08 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | American Health Packaging | dd2215a9-ee0f-443a-a2e3-3d0578c8cd8f | 2025-07-28 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Institutional Inc. | 16f9e4d1-6953-4d4f-b4cf-ad95a856ac25 | 2025-07-18 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | Bryant Ranch Prepack | c3f17bad-f486-4529-90df-5fdab3cb1d0b | 2025-06-04 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Bryant Ranch Prepack | 998f805d-da97-484e-a931-e409e8b8c65a | 2025-04-07 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 2d9469ba-02b2-0cfc-e063-6394a90a6292 | 2025-02-07 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 2cdca970-f077-3a80-e063-6294a90ab335 | 2025-01-29 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.